4//SEC Filing
NORDMANN RONALD M 4
Accession 0000878088-12-000063
CIK 0000878088other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:50 PM ET
Size
22.9 KB
Accession
0000878088-12-000063
Insider Transaction Report
Form 4
NORDMANN RONALD M
Director
Transactions
- Disposition to Issuer
Stock Option (right to Buy)
2012-09-28$18.30/sh−10,000$183,000→ 0 totalExercise: $31.70Exp: 2013-01-14→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2012-09-28$1.25/sh−10,000$12,500→ 0 totalExercise: $48.75Exp: 2013-06-19→ Common Stock (10,000 underlying) - Disposition to Issuer
Restricted Stock Units
2012-09-28$50.00/sh−30,090$1,504,500→ 0 total→ Common Stock (30,090 underlying) - Disposition to Issuer
Stock Option (right to buy)
2012-09-28$16.38/sh−5,000$81,900→ 0 totalExercise: $33.62Exp: 2016-01-08→ Common Stock (5,000 underlying) - Disposition to Issuer
Common Stock
2012-09-28$50.00/sh−4,000$200,000→ 0 total - Disposition to Issuer
Deferred Unit Award/Stock Units
2012-09-28$50.00/sh−1,980$99,000→ 0 total→ Common Stock (1,980 underlying) - Disposition to Issuer
Stock Option (right to buy)
2012-09-28$7.86/sh−5,000$39,300→ 0 totalExercise: $42.14Exp: 2015-01-05→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2012-09-28$23.62/sh−5,000$118,100→ 0 totalExercise: $26.38Exp: 2017-01-30→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]On Sept 28, 2012, certain affiliates of TPG Capital, L.P.("TPG") acquired the Issuer (the "Merger") pursuant to that certain merger agreement, as of July 14, 2012, by and among the Issuer, Sky Growth Holdings Corporation ("Parent") and Sky Growth Acquisition Corporation ("Merger Sub"). In connection with the Merger, TPG acquired all of the outstanding shares of the Issuer's Common Stock at a price of $50 per share, in cash. In addition, all outstanding deferred unit awards, performance stock units, restricted stock units and options (other than such awards held by certain employees that were exchanged for awards of Parent's stock) were cancelled upon the closing of the Merger in exchange for cash payments at a price of $50 per unit or option share (less the exercise price in the case of options), payable without interest. This transaction is more fully described in the Issuer's Proxy Statement filed with the SEC on Aug 27, 2012, as amended.
- [F2]The deferred unit awards and restricted stock units are the economic equivalent of one share of common stock, and are only distributed upon termination of services as a director of the Issuer. The deferred unit awards and restricted stock units were cancelled upon of the closing of the Merger in exchange for a cash payment of $50.00 per unit. In addition, the Reporting Person has resigned as a director of the Company effective upon the closing of the Merger.
- [F3]The options, all of which were exercisable, were cancelled upon the closing of the merger in exchange for a cash payment equal to the number of shares underlying such options multiplied by the difference between the exercise price of such options and the merger consideration of $50.00 per share.
Documents
Issuer
PAR PHARMACEUTICAL COMPANIES, INC.
CIK 0000878088
Entity typeother
Related Parties
1- filerCIK 0001189790
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:50 PM ET
- Size
- 22.9 KB